THC acts on a signalling system that the brain already uses. The brain's own endocannabinoids differ from THC, although these chemicals can act on some of the same receptors.
The YouTube player loads only when you press Play. Playing connects to YouTube, which may use cookies and storage. See Privacy.
Anandamide is a body signal
Anandamide is an endocannabinoid, a signalling molecule that the body produces. Its name derives from the Sanskrit word ananda, meaning bliss. It is chemically different from THC, the main intoxicating cannabinoid in cannabis.
The phrase the brain's own THC is therefore an analogy. It points to a shared receptor system, rather than identical molecules. The difference matters because the body produces and clears the molecules in different ways.
Why the signal travels backward
A synapse is a junction where a neuron communicates with another cell. A neuron is a nerve cell. At a chemical synapse, a sending cell releases a messenger toward a receiving cell.
Endocannabinoids can travel in the reverse direction. Activity in the receiving cell can stimulate their production. They then act on receptors at the sending side and reduce further messenger release.
Scientists call this retrograde signalling. It provides feedback within a circuit. The video's dimmer-switch picture helps explain this local reduction in release.
Reducing a messenger does not always reduce the whole circuit's output. Some messengers stimulate activity, while others restrain it. Reducing a restraint can increase activity elsewhere.
How THC changes the timing
THC activates CB1 receptors involved in this feedback system. CB1 means cannabinoid receptor type 1. Its action changes the signals that the receptor-bearing cell sends.
The body usually produces endocannabinoids in response to local activity and clears them relatively quickly. THC enters from outside the body and can produce effects for hours. It does not follow the same local, on-demand timing.
This does not mean THC reaches every receptor at once or holds every signal at one fixed level. The effect depends on dose, route, time, and the circuit involved.
Memory and coordination
CB1 receptors occur abundantly in the hippocampus and cerebellum. The hippocampus supports learning and memory. The cerebellum helps coordinate movement and timing.
THC can impair short-term memory and reaction time. Those changes help explain difficulties with remembering new information and coordinating a task. The receptor map provides a useful explanation without predicting every person's response.
The appetite example
In a mouse experiment, cannabinoid signalling changed the feeding-related output of hypothalamic POMC neurons. These neurons normally contribute to reduced feeding. Under the experiment's conditions, they instead helped promote feeding.
This gives a mechanism for the appetite effect described in the video. It does not prove that one identical switch explains appetite in every human. Animal evidence and human experience need separate labels.
The risks and the corrected numbers
The video's three-in-ten statement needs a correction. A US survey from 2012–2013 found DSM-IV abuse or dependence in about 30.6% of past-year cannabis users. DSM-IV identifies the diagnostic criteria used in that study.
The survey did not measure the lifetime chance that every new user would develop a disorder. It also did not use later DSM-5 severity categories. Frequent use and starting young increase concern.
Observational research links daily high-potency use with higher odds of psychosis. Psychosis can involve hallucinations, delusions, or loss of contact with reality. An association is important evidence, but does not by itself prove cause.
The fourfold potency comparison concerns historical US police-seized samples. Mean THC content rose from about 4% in 1995 to about 16% in 2022. Those averages do not describe every current product or the dose any person takes.
What this means
THC changes an existing feedback system rather than adding an entirely new brain function. Its longer and less locally controlled action helps explain changes in memory, coordination, and appetite. The same mechanism does not establish safety.
FAQ
Does the brain produce cannabis?
No. The brain produces endocannabinoids such as anandamide. These differ chemically from the plant's THC.
Is three in ten a lifetime prediction?
No. It describes a specific surveyed group and diagnostic definition from 2012–2013.
Does a stronger product affect everyone equally?
No. Dose, route, timing, frequency, and individual differences all matter.
Sources
- Wilson and Nicoll: retrograde cannabinoid signalling
- Huestis: human cannabinoid pharmacokinetics
- Koch and colleagues: cannabinoid-induced feeding in mice
- Hasin and colleagues: US marijuana-use disorder survey
- Review: high-potency cannabis and health
- Cannabis mechanisms, clinical and preclinical evidence
- Cannabinoids and the eye
- CDC: cannabis health effects and questions
- CB1 receptor availability during abstinence
- Di Forti and colleagues: EU-GEI psychosis study
- NIDA: historical potency and cannabis evidence
- University of Maryland: cannabis potency monitoring data
